Tumor Board Conference Thymic Carcinoma - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

Tumor Board Conference Thymic Carcinoma

Description:

... appointment with thoracic surgery, radiation oncology and medical oncology teams. ... Are detected by chance with plain-film chest radiography in 50% of pts ... – PowerPoint PPT presentation

Number of Views:353
Avg rating:3.0/5.0
Slides: 13
Provided by: lifebrid
Category:

less

Transcript and Presenter's Notes

Title: Tumor Board Conference Thymic Carcinoma


1
Tumor Board ConferenceThymic Carcinoma
  • Sinai Hospital of Baltimore
  • Sanjay Munireddy
  • Feb 27, 2007

2
HPI
  • Mr. HH is a 78 yo AA male who presented to Sinai
    ER in May 2006 with c/o rt. arm and rt. leg
    weakness lasting for few hours
  • Had around 10 episodes each of which lasted for
    few hours and resolved
  • Admitted for TIA workup

3
HPI
  • PMH TIAs, CVA Lt. thalamus, GSW to rt. shoulder
    in the past, cardiac murmur, HTN and
    hyperlipidemia
  • ROS negative for myasthenia gravis symptoms,
    asbestos exposure, wt. loss, dysphagia, SOB,
    tobacco
  • PE non-significant findings
  • Labs WBC 14.5
  • Diagnostics Head, Chest CT
  • Chest CT soft tissue mass in the ant.
    mediastinum 4.7 x 2.5 cm

4
Operative Course
  • Went to OR on 5/19/2006
  • Underwent Chamberlain procedure (anterior
    mediastinotomy) on the rt. side and biopsy of the
    mass
  • Mass was unresectable due to the fact that it was
    abutting the ascending aorta

5
Pathology
  • Frozen section while in the OR showed tissue with
    a question of carcinoma
  • Final path report showed features of poorly
    differentiated non-small cell carcinoma vs.
    thymic carcinoma

6
Post-Op Course
  • Pt. was discharged 4 days later
  • Pt had an appointment with thoracic surgery,
    radiation oncology and medical oncology teams.
  • Pt. was started on systemic chemotherapy with
    Taxotere, Erbitux and Carboplatin and also
    received concomitant radiotherapy (total
    cumulative dose of 6120 cGy)

7
Chemotherapy
  • Pt did very well and was in complete remission
    with combined therapy
  • After the conclusion of combined therapy, pt was
    started on Gleevec and then later Tarceva both
    which he did not tolerate well
  • Plan to start single therapy with Erbitux

8
Thymic Carcinoma
  • Relatively rare malignant epithelial tumor of
    thymus represents about 0.2 to 1.5 of all
    malignancies
  • Accounts for only 0.06 of all thymic neoplasms
  • Most patients are aged 40 through 60 years.
  • Etiology is not known.
  • Are detected by chance with plain-film chest
    radiography in 50 of pts
  • 90 occur in the anterior mediastinum.

9
Thymic Carcinoma
  • Approximately 30 of the patients are
    asymptomatic at the time of diagnosis.
  • Presenting signs/symptoms include cough, chest
    pain and signs of upper airway congestion
  • Most patients present with advanced disease
    (stage III or IV) that manifests as mediastinal
    masses

10
Work-Up
  • Chest radiograph is indicated.
  • CT scan or MRI in addition to PET scan is
    indicated in all patients with a suspected mass.
  • FNA and core needle biopsy are indicated.
  • Mediastinoscopy provides large tissue sample.
  • Immunohistochemistry provides the most useful
    method to differentiate thymic carcinoma from
    other similar neoplasms

11
Thymic Carcinoma
  • Standard primary treatment is surgical with en
    bloc resection which has the best long-term
    result.
  • The mortality rate is more than 85 in reported
    cases
  • Median survival among patients with incompletely
    resected tumors is 12-36 months

12
Thymic Carcinoma
  • Multimodal treatment, especially complete
    resection and postoperative radiotherapy with or
    without chemotherapy, is a curative therapy for
    thymic carcinomas1
  • Radiotherapy plays an important role in treating
    thymic carcinoma in terms of reducing local
    recurrence and prolonging survival time2
  • 1 Ogawa K et. al Cancer 2002 Jun 1594(12)3115-9
  • 2 Nonaka T et. Al Japan J Clinical Onc 2004
    Dec34(12)722-6.
Write a Comment
User Comments (0)
About PowerShow.com